buprenorphine
buprenorphine is listed in the FDA National Drug Code directory with 14 NDC codes, marketed under brand names including Butrans, SUBLOCADE, buprenorphine transdermal system. Available dosage forms: patch, extended release, solution.
Drug Details
- Generic Name
- buprenorphine
- Brand Names
- Butrans, SUBLOCADE, buprenorphine transdermal system
- Application Number
- NDA021306
- Sponsor
- Knoa Pharma LLC
- NDC Codes
- 14
- Dosage Forms
- PATCH, EXTENDED RELEASE, SOLUTION
- Routes
- TRANSDERMAL, SUBCUTANEOUS
- Active Ingredients
- BUPRENORPHINE
Indications and Usage
1 INDICATIONS AND USAGE Buprenorphine Sublingual Tablets are indicated for the treatment of opioid dependence and are preferred for induction. Buprenorphine Sublingual Tablets should be used as part of a complete treatment plan to include counseling and psychosocial support. Buprenorphine Sublingual Tablets contain buprenorphine, a partial opioid agonist, and is indicated for the treatment of opioid dependence and is preferred for induction. ( 1 ) Buprenorphine Sublingual Tablets should be used as part of a complete treatment plan that includes counseling and psychosocial support. ( 1 )